Expand BCRX Menu
BCRX MENU

BCRX Latest Press Releases

-- December 12, 2025 --

BioCryst Announces FDA Approval of ORLADEYO (berotralstat) Oral Pellets, First and Only Oral Prophylactic Treatment for Patients with HAE Aged 2 to <12 Years Globe Newswire 7:00 AM

-- December 4, 2025 --

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:00 AM

-- December 3, 2025 --

BioCryst Receives Early Termination of HSR Waiting Period for Astria Acquisition Globe Newswire 7:00 AM

-- November 12, 2025 --

Astria Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update Business Wire 8:00 AM

-- November 5, 2025 --

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:01 AM
BioCryst to Present at Upcoming Investor Conference Globe Newswire 7:00 AM

-- November 3, 2025 --

BioCryst Reports Third Quarter 2025 Financial Results and Provides Business Update Globe Newswire 7:00 AM

-- October 23, 2025 --

BioCryst to Present New Pediatric HAE Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting Globe Newswire 7:00 AM

-- October 20, 2025 --

BioCryst to Report Third Quarter 2025 Financial Results on November 3 Globe Newswire 7:00 AM

-- October 17, 2025 --

Astria Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Astria Therapeutics, Inc. - ATXS Business Wire 3:20 PM

-- October 14, 2025 --

BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile Globe Newswire 7:00 AM
BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile Business Wire 7:00 AM

-- October 3, 2025 --

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:00 AM

-- October 1, 2025 --

BioCryst Completes Sale of European ORLADEYO (berotralstat) Business Globe Newswire 7:00 AM

-- September 3, 2025 --

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:00 AM

-- August 21, 2025 --

BioCryst to Present at Upcoming Investor Conference Globe Newswire 7:00 AM

-- August 11, 2025 --

BioCryst Announces Departure of Dr. Helen Thackray Globe Newswire 7:00 AM

-- August 6, 2025 --

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:00 AM

-- August 4, 2025 --

BioCryst Reports Second Quarter 2025 Financial Results and Provides Business Update Globe Newswire 7:00 AM

-- July 31, 2025 --

BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse as Chief Executive Officer Upon his Retirement in December Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes